GNRH1 and endometrial cancer: Future studies with GnRH-(1–5) should investigate its effects on other growth factors and related signaling pathways highly implicated in endometrial cancer, such as transforming growth factor beta (TGFβ), vascular endothelial growth factor (VEGF), and platelet-derived growth factor (PDGF) (76–80).